Neurocrine Biosciences, Inc. · NASDAQ:NBIX

Lyons Gary A sold 15,000 Neurocrine Biosciences, Inc. shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 19, 2026

On Nov 17, 2026, Lyons Gary A (Director) sold 15,000 Neurocrine Biosciences, Inc. shares at an average US$164.87 for US$2.47M under a trading plan, leaving 122,141 shares. Filed Nov 19, 2026 (Form 4).

Sold
15,000 shares
Price
US$164.87 average (US$163.11 to US$165.90)
Value
US$2.47M
Holding after
122,141 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common StockOption exercise15,000US$53.64137,141Direct
Nov 17, 2026Common StockSale1,200US$163.11135,941Direct
Nov 17, 2026Common StockSale4,011US$163.94131,930Direct
Nov 17, 2026Common StockSale5,689US$165.15126,241Direct
Nov 17, 2026Common StockSale4,100US$165.90122,141Direct

Source

Download original · View original at SEC

Related